Analysis of Prognostic Determinants of Scleroderma-Associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension

被引：0
|
作者：
Hannan, Alexander [1 ]
Dweik, Raed [2 ]
Highland, Kristin B. [3 ]
Heresi, Gustavo [4 ]
Tonelli, Adriano [4 ]
Messner, William [5 ]
Chatterjee, Soumya [1 ]
机构：
[1] Cleveland Clin, Rheumat & Immunol Dis, Cleveland, OH 44106 USA
[2] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA
[3] Cleveland Clin, Rheumatol Org, Cleveland, OH 44106 USA
[4] Cleveland Clin, Resp Inst, Pulm Med, Cleveland, OH 44106 USA
[5] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2680
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Risk assessment in Scleroderma-associated pulmonary arterial hypertension
    Mercurio, Valentina
    Diab, Nermin
    Peloquin, Grace
    Housten-Harris, Traci
    Damico, Rachel
    Kolb, Todd M.
    Mathai, Stephen C.
    Hassoun, Paul M.
    VASCULAR PHARMACOLOGY, 2020, 132
  • [2] Scleroderma pulmonary arterial hypertension: the same as idiopathic pulmonary arterial hypertension?
    Khan, Sarah L.
    Mathai, Stephen C.
    CURRENT OPINION IN PULMONARY MEDICINE, 2023, 29 (05) : 380 - 390
  • [3] Esophageal Dysmotility in Patients With Scleroderma-Associated Pulmonary Arterial Hypertension
    Selvachandran, Adarsha
    Yap, Vanessa
    Foley, Raymond
    Datta, Debapriya
    CHEST, 2017, 152 (04) : 987A - 987A
  • [4] Practical approach to screening for scleroderma-associated pulmonary arterial hypertension
    Fischer, Aryeh
    Bull, Todd M.
    Steen, Virginia D.
    ARTHRITIS CARE & RESEARCH, 2012, 64 (03) : 303 - 310
  • [5] Determinants of pulmonary arterial hypertension in scleroderma
    Plastiras, Sotiris C.
    Karadimitrakis, Stylianos P.
    Kampolis, Christos
    Moutsopoulos, Haralampos M.
    Tzelepis, George E.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2007, 36 (06) : 392 - 396
  • [6] Pulmonary vascular capacitance is a strong predictor of mortality in patients with idiopathic and scleroderma-associated pulmonary arterial hypertension
    Skouri, Hadi N.
    Abrahams, Zuheir
    Mullens, Wilfried
    Taylor, David O.
    Minai, Omar A.
    CHEST, 2007, 132 (04) : 636S - 636S
  • [7] Pulmonary vascular capacitance is a strong predictor of mortality in patients with idiopathic and scleroderma-associated pulmonary arterial hypertension
    Minai, Omar A.
    Skouri, H.
    Taylor, D.
    CRITICAL CARE MEDICINE, 2007, 35 (12) : A219 - A219
  • [8] Validating The Sf-36 In Scleroderma-Associated Pulmonary Arterial Hypertension
    Khair, R. M.
    Kolb, T. M.
    Damico, R. L.
    Hassoun, P. M.
    Mathai, S. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [9] Renal Dysfunction and Disease Severity in Scleroderma-Associated Pulmonary Arterial Hypertension
    Mathai, Stephen C.
    Hummers, Laura K.
    Steen, Virginia D.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S310 - S310
  • [10] Exercise Parameters Predict the Development of Scleroderma-Associated Pulmonary Arterial Hypertension
    Vasilottos, N.
    Khanna, D.
    McLaughlin, V. V.
    Visovatti, S. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345